Skip Content
You are currently on the new version of our website. Access the old version .
  • Tracked for
    Impact Factor
  • Indexed in
    Scopus
  • 22 days
    Time to First Decision

Pharmacoepidemiology, Volume 3, Issue 1

2024 March - 11 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (11)

  • Article
  • Open Access
3,390 Views
15 Pages

In this cross-sectional descriptive study conducted in the Ratnapura district, Sri Lanka, we assessed the affordability of oral pediatric anti-infective medicines (OPAIMs). Using a modified WHO/HAI medicinal price methodology, we examined the availab...

  • Article
  • Open Access
2,010 Views
14 Pages

Pioneering Arterial Hypertension Phenotyping on Nationally Aggregated Electronic Health Records

  • Jing Wei Neo,
  • Qihuang Xie,
  • Pei San Ang,
  • Hui Xing Tan,
  • Belinda Foo,
  • Yen Ling Koon,
  • Amelia Ng,
  • Siew Har Tan,
  • Desmond Teo and
  • Sreemanee Raaj Dorajoo
  • + 6 authors

Background: Hypertension is frequently studied in epidemiological studies that have been conducted using retrospective observational data, either as an outcome or a variable. However, there are few validation studies investigating the accuracy of hyp...

  • Review
  • Open Access
7 Citations
11,466 Views
52 Pages

Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease

  • Teimur Kayani,
  • Bachar Ahmad,
  • Rachel S. Chang,
  • Frank Qian,
  • Melis Sahinoz,
  • Muhammad Waqar Rehan,
  • Antonio Giaimo,
  • Erica S. Spatz and
  • Jiun-Ruey Hu

Although statins have served as the cornerstone for pharmacological lowering of lipid levels in atherosclerotic cardiovascular disease (ASCVD) risk reduction, many patients are unable to achieve target doses of statin medication due to side effects o...

  • Article
  • Open Access
2,670 Views
14 Pages

Treatment Patterns, Effectiveness, and Safety of Originator Insulin Glargine versus Insulin Glargine-yfgn within the Veterans Health Administration

  • Samantha Walczuk,
  • Francesca E. Cunningham,
  • Xinhua Zhao,
  • Diane Dong,
  • Peter A. Glassman,
  • Donald R. Miller,
  • Deborah Khachikian,
  • Anthony Au,
  • Cedric Salone and
  • Sherrie L. Aspinall
  • + 2 authors

We described insulin glargine (originator) and insulin glargine-yfgn (biosimilar) treatment patterns, assessed effectiveness and safety outcomes, and identified reasons for switching back to the originator product from the biosimilar. This retrospect...

  • Article
  • Open Access
3,006 Views
9 Pages

22 February 2024

Opioids are highly effective drugs but need close monitoring to avoid harm to patients. The aim of this study was to analyze how guideline recommendations are met for (i) the avoidance of the concomitant use of anxiolytics, hypnotics, or sedatives; (...

  • Review
  • Open Access
12 Citations
7,100 Views
12 Pages

Helicobacter pylori is a class I carcinogen that infects more than 100 million individuals in the United States. Antimicrobial therapy for H. pylori has typically been prescribed empirically rather than based on susceptibility testing. Until recently...

  • Review
  • Open Access
5 Citations
6,340 Views
13 Pages

Severe acute respiratory syndrome coronavirus 2 has infected millions of people, but about 20% of infected individuals do not develop symptoms. COVID-19 is an inflammatory disease that affects a portion of individuals infected with the virus and it i...

  • Article
  • Open Access
3 Citations
5,453 Views
12 Pages

“My Addiction Doesn’t Define Me”—Experiences of Stigma among Mothers with Opioid Use Disorder

  • Christine Bakos-Block,
  • Andrea Yatsco,
  • A. Sarah Cohen,
  • Francine Vega and
  • Tiffany Champagne-Langabeer

Opioid use in women has increased by 300% since 1999, and opioid use disorder among pregnant women has quadrupled. The stigma of substance use disorder is a significant barrier to treatment, especially among women. The purpose of this study was to ex...

  • Article
  • Open Access
2,867 Views
6 Pages

Tofacitinib is a Janus kinase inhibitor (JAKi) that is used off-label for the treatment of alopecia areata (AA). Its boxed warning includes an increased risk of serious adverse events (SAEs) based on the results of a safety trial in rheumatoid arthri...

  • Article
  • Open Access
2 Citations
3,326 Views
18 Pages

Rescue Therapy for Supratherapeutic Concentrations of Calcineurin Inhibitors Using Potent Cytochrome P450 Inducers

  • Seth Duwor,
  • Katharina Enthofer,
  • Christoph Ganter,
  • Prabin Poudel,
  • Anna Svarin and
  • Gerd A. Kullak-Ublick

Introduction: Calcineurin inhibitors (CNIs), ciclosporin and tacrolimus, are utilized primarily in organ transplantation and the treatment of autoimmune diseases. Since patients depend on these drugs over long periods, they face a potential risk of i...

  • Article
  • Open Access
4 Citations
3,379 Views
37 Pages

Direct Oral Anticoagulants’ Consumption and Expenditure in the COVID-19 Pandemic in Russia and Clinical Practice Guidelines for Their Use

  • Elena A. Baybulatova,
  • Mikhail S. Chenkurov,
  • Elina A. Korovyakova,
  • Sergey K. Zyryanov and
  • Liliya Eugenevna Ziganshina

Background: The coronavirus pandemic has led to the creation of clinical guidelines by a large number of professional medical communities. However, the quality and methodology of development of Russian clinical guidelines has been little studied. The...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmacoepidemiology - ISSN 2813-0618